The Food and Drug Administration Recently Consented to Moderna Inc’s (NASDAQ: MRNA) COVID 19 Children Vaccine

The Food and Drug Administration recently authorised the administration of Moderna Inc’s  (NASDAQ: MRNA) coronavirus vaccine to infants or minors. During the announcement, the Authority disclosed that the vaccine was effective and guarded, thus creating the platform for evaluating the agency’s consultancy platforms before the week concludes. The Authority further announced that it would conduct […]

Flora Growth Corp (NASDAQ:FLGC) intends to explore a preventative application against COVID-19

Recently, Flora Growth Corp. (NASDAQ:FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced the addition of Vessel founder and CEO, James Choe, to its executive team. “We are excited not only to have added an incredible company like Vessel to our brand portfolio but to be […]

Pfizer Inc (NYSE: PFE), Moderna Inc (NASDAQ: MRNA) and Johnson & Johnson (NYSE: JNJ) Booster Jabs For All Who Are 18+, Six Months After Receiving The Second Dose

Pfizer Inc (NYSE: PFE), Moderna Inc (NASDAQ: MRNA) and Johnson & Johnson (NYSE: JNJ) booster dose of the vaccine against coronavirus is administered. Those above 18 can select which booster dose they want Those over 18-years of age can select which of the three dosages they wish to be administered. Pfizer and Moderna booster shot […]

Why 2022 Could Open Gangbusters for Covid Stocks (AZN, OTLC, NVAX, PFE, MRNA, MRK, JNJ, BNTX)

If you think the pandemic is yesterday’s news, think again. One of the nation’s top doctors recently warned that the US could very soon start seeing as many as a million new Covid-19 cases every day due to the lightspeed spread of the new and recently emerging Omicron variant. Retiring NIH Director, Dr. Francis Collins, […]

Covid Stocks Set for Continued Interest on Global Omicron Surge (NVAX, OTLC, PFE, AZN, MRNA, MRK, JNJ, BNTX)

We are finally starting to get hard data on the Omicron variant of Covid-19 from its epicenter in Gauteng, South Africa. And that data, along with data on the variant from the UK, paint a picture of a flash fire spreading at unimaginable speed through populations likely already around the world. The major finding from […]

The Center for Disease Control and Prevention Approves Moderna Inc (NASDAQ: MRNA) and Pfizer Inc. (NYSE: PFE) COVID-19 Boosters

An independent committee that advises the Center for Disease Control and Prevention (CDC) agreed to recommend Moderna Inc (NASDAQ: MRNA) and Pfizer Inc. (NYSE: PFE) COVID-19 boosters for people aged 18 and above. They said that healthcare workers could give the booster six months after the second dose. Dr. Rochelle Walensky made the recommendation official […]

Therapeutics Candidates in Focus as Covid Data Heads Back to Front Burner (MRK, OTLC, PFE, JNJ, NVAX, BNTX, AZN, MRNA)

We are increasingly seeing signs that the pandemic is hardly over. The European Union is battling record case levels. Areas of the US are starting to see some similar dynamics. Hospitals in the developed world are beginning to fill back up with Covid patients. It’s a familiar pattern. This shouldn’t come as a total shock as […]

Top Biotech Opportunities for the End-of-Year Run (CRSP, ATRX, PTPI, ALNA, MRNA, VRTX, IBB)

The Biotech space made a big move on Wednesday, sparking a rebirth in excitement about the space following the Federal Reserve’s move to start tapering its bond purchases. The move was expected to be a big hurdle for tech stocks, including biotechs. Instead, we got a melt-up, which included a breakout to new multi-month highs […]

Analysts Make the Case for Small-Cap Biotech Stocks This Fall (INMB, DVAX, SAVA, ICPT, IMGN, ATRX)

With the dominance of the giants in the Covid vaccine space, biotech stocks have outperformed the market this year by a wide margin. But almost all of that outperformance has been isolated in the large-cap factor zone in the space, leaving small-cap biotech players to badly lag the market. The Nasdaq Biotech Index, which is […]

Desperation on Variants Paints Path for Long-Term Vaccine Thesis (DYAI, MRNA, PFE, JNJ, NVAX, BNTX, AZN, SRNE)

The future of vaccine stocks can probably best be extrapolated from recent moves out of the Biden administration to approve the concept of booster shots, and then various swirling rumors about the idea of shortening the window for third-shot administration. First, earlier this month, we heard news that the administration had approved the idea of […]

Moderna Inc.’s (NASDAQ: MRNA) Vaccine Effective Against Delta Variant Than Pfizer Inc.’s (NYSE: PFE), Study Shows

A study by Mayo Clinic has shown that the risk of someone vaccinated with the Moderna Inc. (NASDAQ: MRNA) vaccine getting infected with the delta variant is lower compared to someone who received the Pfizer Inc. (NYSE: PFE) vaccine.  Moderna vaccine offers more protection than Pfizer vaccine  Results of the study awaiting review established that, […]

Moderna bounces back with spotlight on other vaccine stocks (MRNA, DYAI, NVAX, JNJ, AZN, BNTX, PFE)

Stock of Moderna (MRNA) is currently trading at $396.33 USD up 2.85% today. The week has been full on volatility with stock prices gaining 17% on Monday, lagging 5.7% on Tuesday, and fell again on Wednesday. The entire year 2021 has been a dream year for MRNA. Moderna  surged by over 300% over that period, […]

Vaccine Plays in Focus as the World Searches for a Long-term Solution (MRNA, DYAI, NVAX, JNJ, AZN, BNTX, PFE)

The Delta variant has demonstrated a likely course for our Covid future – a new endemic piece of the global human microbiome puzzle. It’s not the news we wanted. But it could have turned out a lot worse.  Covid is amenable to vaccine solutions, even if we may have to come up with modified versions […]